These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11550568)

  • 41. [The cytokine-inducing activity of the Yersinia pestis "murine" toxin].
    Vasil'eva GI; Mishan'kin MB; Kozlovskiĭ VN; Verkina LM; Mishan'kin BN
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (1):61-4. PubMed ID: 9532689
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recombinant capsular antigen (fraction 1) from Yersinia pestis induces a protective antibody response in BALB/c mice.
    Simpson WJ; Thomas RE; Schwan TG
    Am J Trop Med Hyg; 1990 Oct; 43(4):389-96. PubMed ID: 2240367
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [A comparative cytofluorimetric analysis of the blood leukocytes in guinea pigs exposed to the phospholipase D and antigens of the causative agent of plague].
    Sinichkina NA; Kravtsov AL; Naumov AV; Kuz'michenko IA; Taranenko TM; Zadumina SIu
    Zh Mikrobiol Epidemiol Immunobiol; 1992; (11-12):52-4. PubMed ID: 1301664
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Application of r-PFE hyperimmune sera for concurrent detection of Bacillus anthracis, Yersinia pestis and staphylococcal enterotoxin B.
    Balakrishna K; Tuteja U; Murali HS; Batra HV
    J Appl Microbiol; 2014 Jun; 116(6):1465-73. PubMed ID: 24905217
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Salmonella enterica serovar Typhi vaccine expressing Yersinia pestis F1 antigen on its surface provides protection against plague in mice.
    Morton M; Garmory HS; Perkins SD; O'Dowd AM; Griffin KF; Turner AK; Bennett AM; Titball RW
    Vaccine; 2004 Jun; 22(20):2524-32. PubMed ID: 15193377
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Features of regulatory system function in platelets under the effect of plague toxin].
    Cherkasova TD; Iurkiv VA
    Vopr Med Khim; 1994; 40(6):17-20. PubMed ID: 7618291
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effect of immunomodulators of organometallic nature on the sensitivity to plague toxin].
    Kirillicheva GB; Baturina IG; Rozhkov KK; Ignatenko MA
    Biull Eksp Biol Med; 1993 Mar; 115(3):282-4. PubMed ID: 8054625
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Cloning and detailed mapping of the fra-ymt region of the Yersinia pestis pFra plasmid].
    Cherepanov PA; Mikhaĭlova TG; Karimova GA; Zakharova NM; Ershov IuV; Volkovoĭ KI
    Mol Gen Mikrobiol Virusol; 1991 Dec; (12):19-26. PubMed ID: 1787840
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Interleukin-1-inducing activity of the polysaccharide-containing antigens of the cell wall in Yersinia pestis].
    Isin ZhM; Tugambaev TI; Tleulieva RT; Beliaev NN; Filimonov NG
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Nov; (11):71-6. PubMed ID: 2694696
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of encapsulated and non-encapsulated Yersinia pestis by immunofluorescence tests using polyclonal and monoclonal antibodies.
    Phillips AP; Morris BC; Hall D; Glenister M; Williams JE
    Epidemiol Infect; 1988 Aug; 101(1):59-73. PubMed ID: 3042439
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Change in the glycogen level in the liver, heart and skeletal muscles of rodents during exposure to plague toxin].
    Kratinov AG; Khar'kova NM
    Vopr Med Khim; 1971; 17(4):373-9. PubMed ID: 5317618
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New genes involved in Yersinia pestis fraction I biosynthesis.
    Feodorova VA; Devdariani ZL
    J Med Microbiol; 2001 Nov; 50(11):969-978. PubMed ID: 11699594
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recombinant murine toxin from Yersinia pestis shows high toxicity and β-adrenergic blocking activity in mice.
    Fan Y; Zhou Y; Feng N; Wang Q; Tian G; Wu X; Liu Z; Bi Y; Yang R; Wang X
    Microbes Infect; 2016 May; 18(5):329-35. PubMed ID: 26774329
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection and isolation of Yersinia pestis without fraction 1 antigen by monoclonal antibody in foods and water.
    Zhao T; Zhao P; Doyle MP
    J Food Prot; 2012 Sep; 75(9):1555-61. PubMed ID: 22947461
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Altered lethality of murine toxin from Yersinia pestis under various metabolic conditions.
    Wennerstrom DE; Brown SD; Montie TC
    Proc Soc Exp Biol Med; 1977 Jan; 154(1):78-81. PubMed ID: 190614
    [No Abstract]   [Full Text] [Related]  

  • 56. [Various physico-chemical properties of the Yersinia pestis capsular protein].
    Anisimov PI; Serdobintsev LN; Ivanov IuV; Taranenko TM; Naumov AV
    Mol Gen Mikrobiol Virusol; 1987 Feb; (2):24-7. PubMed ID: 3574316
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antiplague antibodies against Yersinia pestis fraction-I antigen in serum from rodents either experimentally infected or captured in harbor areas of Japan, 1971--1977.
    Suzuki S; Hotta S
    Microbiol Immunol; 1979; 23(12):1157-68. PubMed ID: 537520
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A new purification strategy for fraction 1 capsular antigen and its efficacy against Yersinia pestis virulent strain challenge.
    Wang T; Qi Z; Wu B; Zhu Z; Yang Y; Cui B; Dai R; Zhang Q; Qiu Y; Wang Z; Wang H; Guo Z; Wang X; Yang R
    Protein Expr Purif; 2008 Sep; 61(1):7-12. PubMed ID: 18539482
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The isolation and characteristics of variant plague microbes not producing the capsular antigen].
    Gvozdenko NA; Ryzhkov VIu; Pavlovich NV
    Mikrobiol Zh (1978); 1990; 52(6):13-7. PubMed ID: 2097497
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Studies of Yersinia pestis in wild animals captured in Ankara, Konya and Nevsehir].
    Ozsan K; Fazli A; Aktan M; Beyoğlu K
    Mikrobiyol Bul; 1976 Jan; 10(1):35-56. PubMed ID: 933892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.